Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
83,924,060
-
Shares change
-
+19,138,078
-
Total reported value, excl. options
-
$1,633,423,112
-
Value change
-
+$391,433,047
-
Put/Call ratio
-
57%
-
Number of buys
-
114
-
Number of sells
-
57
-
Price
-
$19.48
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2020
As of 30 Jun 2020 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 83,924,060 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GREAT POINT PARTNERS LLC, Eversept Partners, LP, ALKEON CAPITAL MANAGEMENT LLC, Artal Group S.A., and Candriam Luxembourg S.C.A..
This table shows 172 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.